PDS Biotechnology Corporation
PDSB · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $59,418 | $153,831 | $377,507 | $207,336 |
| - Cash | $41,690 | $56,561 | $73,820 | $65,243 |
| + Debt | $21,828 | $23,852 | $23,473 | $490 |
| Enterprise Value | $39,557 | $121,123 | $327,160 | $142,583 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$60 | -$57 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$33,747 | -$40,085 | -$40,737 | -$21,430 |
| % Margin | – | – | – | – |
| Net Income | -$37,610 | -$42,942 | -$40,855 | -$16,918 |
| % Margin | – | – | – | – |
| EPS Diluted | -1.03 | -1.39 | -1.43 | -0.66 |
| % Growth | 25.9% | 2.8% | -116.7% | – |
| Operating Cash Flow | -$35,030 | -$33,636 | -$25,710 | -$12,486 |
| Capital Expenditures | -$29 | $0 | $0 | $0 |
| Free Cash Flow | -$35,059 | -$33,636 | -$25,710 | -$12,486 |